Sofpironium bromide: a novel solution in the battle against primary axillary hyperhidrosis.
作者信息
Rashmeen Syeda, Sohail Iza, Mohsin Maria, Anwar Diya, Farhat Solay, Shahnoor Syeda, Maryyum Adeena, Khan Abdul Moiz
机构信息
Department of Internal Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
Department of Internal Medicine, Ayub Medical College, Abbottabad, Pakistan.
出版信息
Ann Med Surg (Lond). 2025 Feb 28;87(5):2526-2528. doi: 10.1097/MS9.0000000000003093. eCollection 2025 May.
Abstract
摘要
相似文献
1
Sofpironium bromide: a novel solution in the battle against primary axillary hyperhidrosis.溴化索非罗宁：对抗原发性腋窝多汗症的新方法。
Ann Med Surg (Lond). 2025 Feb 28;87(5):2526-2528. doi: 10.1097/MS9.0000000000003093. eCollection 2025 May.
2
Effectiveness of Sofpironium Bromide in Patients with Primary Axillary Hyperhidrosis Who Experienced Residual or Recurrence of Axillary Odor after Surgery for Axillary Osmidrosis.对于腋臭手术后出现腋窝异味残留或复发的原发性腋窝多汗症患者，溴化索波铵的有效性。
J Plast Reconstr Surg. 2024 Jul 5;4(1):13-19. doi: 10.53045/jprs.2023-0067. eCollection 2025 Jan 27.
3
Two-week prospective observational study of 5% sofpironium bromide gel in Japanese patients with primary axillary hyperhidrosis.5% 索罗溴铵凝胶治疗日本原发性腋窝多汗症患者的两周前瞻性观察研究。
J Dermatol. 2022 Jun;49(6):594-599. doi: 10.1111/1346-8138.16384. Epub 2022 Apr 8.
4
Efficacy and safety of sofpironium in treatment of primary hyperhidrosis: a systematic review.索非罗尼治疗原发性多汗症的疗效与安全性：一项系统评价
J Dermatolog Treat. 2025 Dec;36(1):2441258. doi: 10.1080/09546634.2024.2441258. Epub 2024 Dec 13.
5
A phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis.一项针对日本原发性腋窝多汗症患者的3期、多中心、随机、双盲、赋形剂对照、平行组研究，使用5%溴化索非罗尼（BBI-4000）凝胶。
J Dermatol. 2021 Mar;48(3):279-288. doi: 10.1111/1346-8138.15668. Epub 2021 Jan 7.
6
A phase III, 52-week, open-label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis.一项为期 52 周、开放标签、III 期研究，旨在评估 5%溴化双环索泮（BBI-4000）凝胶在日本原发性腋窝多汗症患者中的安全性和疗效。
J Dermatol. 2021 Aug;48(8):1149-1161. doi: 10.1111/1346-8138.15927. Epub 2021 May 26.
7
Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: A phase II, randomized, controlled, double-blinded trial.外用溴化索罗那新凝胶治疗腋窝多汗症的疗效与安全性：一项II期随机对照双盲试验。
J Am Acad Dermatol. 2020 Jun;82(6):1321-1327. doi: 10.1016/j.jaad.2020.02.016. Epub 2020 Feb 15.
8
Sofpironium Bromide: First Approval.溴索斯的铵 | 首个批准
Drugs. 2020 Dec;80(18):1981-1986. doi: 10.1007/s40265-020-01438-1.
9
Sofpironium topical gel, 12.45%, for the treatment of axillary hyperhidrosis: Pooled efficacy and safety results from 2 phase 3 randomized, controlled, double-blind studies.用于治疗腋窝多汗症的12.45%索非吡啶 topical凝胶：两项3期随机、对照、双盲研究的汇总疗效和安全性结果。
J Am Acad Dermatol. 2025 Jul;93(1):82-88. doi: 10.1016/j.jaad.2025.02.086. Epub 2025 Mar 5.
10
Efficacy of 5% sofpironium bromide gel in Duchenne muscular dystrophy with palmoplantar hyperhidrosis: A retrospective case study.5% 溴化索罗匹铵凝胶治疗杜氏肌营养不良伴掌跖多汗症的疗效：一项回顾性病例研究。
J Dermatol. 2024 Jan;51(1):135-139. doi: 10.1111/1346-8138.16990. Epub 2023 Oct 5.
本文引用的文献
1
Investigational topical anticholinergics in clinical development for the treatment of hyperhidrosis.处于治疗多汗症临床开发阶段的研究性局部用抗胆碱能药物。
Expert Opin Investig Drugs. 2021 May;30(5):479-482. doi: 10.1080/13543784.2021.1900114. Epub 2021 Apr 16.
2
Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: A phase II, randomized, controlled, double-blinded trial.外用溴化索罗那新凝胶治疗腋窝多汗症的疗效与安全性：一项II期随机对照双盲试验。
J Am Acad Dermatol. 2020 Jun;82(6):1321-1327. doi: 10.1016/j.jaad.2020.02.016. Epub 2020 Feb 15.
3
Hyperhidrosis Prevalence: A Disease Underreported by Patients and Underdiagnosed by Physicians.多汗症患病率：一种患者报告不足且医生诊断不足的疾病。
Indian Dermatol Online J. 2019 Nov 1;10(6):676-681. doi: 10.4103/idoj.IDOJ_55_19. eCollection 2019 Nov-Dec.
4
The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review: Etiology and clinical work-up.多汗症的病因、诊断和治疗：全面综述：病因和临床评估。
J Am Acad Dermatol. 2019 Sep;81(3):657-666. doi: 10.1016/j.jaad.2018.12.071. Epub 2019 Jan 31.
5
Hyperhidrosis--causes and treatment of enhanced sweating.多汗症——出汗增多的原因及治疗
Dtsch Arztebl Int. 2009 Jan;106(3):32-7. doi: 10.3238/arztebl.2009.0032. Epub 2009 Jan 16.
6
Axillary hyperhidrosis treated with alcoholic solution of aluminium chloride hexahydrate.用六水合氯化铝酒精溶液治疗腋窝多汗症。
Br Med J. 1978 Jul 8;2(6130):84-5. doi: 10.1136/bmj.2.6130.84.
Zotero 插件